The FDA approved Lupin Pharmaceutical's generic version of Roche's Tamiflu capsules Thursday, according to Money Control.
Here are three things to know.
1. The drug, which is an oseltamivir phosphate capsule, will be sold in strengths of 30 mg, 45 mg and 75 mg.
2. The capsules are approved to treat acute, uncomplicated influenza A and B in patients two-weeks of age and older.
3. Shares of Lupin, which is a drugmaker based in Mumbai, India, closed 0.46 percent up on the BSE stock exchange following the announcement.